These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19967049)

  • 1. Expression of endothelin-1 and its receptors in Cisplatin-induced acute renal failure in mice.
    Lee S; Ahn D
    Korean J Physiol Pharmacol; 2008 Aug; 12(4):149-53. PubMed ID: 19967049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gender differences in ischemic and nephrotoxic acute renal failure.
    Wei Q; Wang MH; Dong Z
    Am J Nephrol; 2005; 25(5):491-9. PubMed ID: 16155358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.
    Ruschitzka F; Shaw S; Gygi D; Noll G; Barton M; Lüscher TF
    J Am Soc Nephrol; 1999 May; 10(5):953-62. PubMed ID: 10232680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endothelin in the pathogenesis of acute renal failure.
    Takaoka M; Kuro T; Matsumura Y
    Drug News Perspect; 2000 Apr; 13(3):141-6. PubMed ID: 12937604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective ET(A) receptor blockade protects against cisplatin-induced acute renal failure in male rats.
    Helmy MM; Helmy MW; Abd Allah DM; Abo Zaid AM; Mohy El-Din MM
    Eur J Pharmacol; 2014 May; 730():133-9. PubMed ID: 24632086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats.
    Shimizu T; Kuroda T; Ikeda M; Hata S; Fujimoto M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):977-83. PubMed ID: 9694958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure.
    Yanagisawa H; Nodera M; Umemori Y; Shimoguchi Y; Wada O
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):315-26. PubMed ID: 9853001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats.
    Kusumoto K; Kubo K; Kandori H; Kitayoshi T; Sato S; Wakimasu M; Watanabe T; Fujino M
    Life Sci; 1994; 55(4):301-10. PubMed ID: 8028448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure.
    Nishida M; Ieshima M; Konishi F; Yamashita J; Takaoka M; Matsumura Y
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):586-93. PubMed ID: 12352321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function.
    Knoll T; Schult S; Birck R; Braun C; Michel MS; Bross S; Juenemann KP; Kirchengast M; Rohmeiss P
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):483-8. PubMed ID: 11300661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin up-regulation and localization following renal ischemia and reperfusion.
    Wilhelm SM; Simonson MS; Robinson AV; Stowe NT; Schulak JA
    Kidney Int; 1999 Mar; 55(3):1011-8. PubMed ID: 10027938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-targeting of endothelin-
    Abdel Moneim LM; Helmy MW; El-Abhar HS
    Pharmacol Rep; 2019 Oct; 71(5):917-925. PubMed ID: 31430707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary endothelin-1 in children with acute renal failure of tubular origin.
    Tsau YK; Tsai WS; Chen CH
    J Formos Med Assoc; 1998 Jun; 97(6):387-91. PubMed ID: 9650466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure.
    Jerkić M; Miloradović Z; Jovović D; Mihailović-Stanojević N; Elena JV; Nastić-Mirić D; Grujić-Adanja G; Rodríguez-Barbero A; Marković-Lipkovski J; Vojvodić SB; Manero MV; Prieto MP; López-Novoa JM
    Nephrol Dial Transplant; 2004 Jan; 19(1):83-94. PubMed ID: 14671043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular endothelin receptors during initiation and maintenance of ischemic acute renal failure in rats.
    Wilkes BM; Pearl AR; Mento PF; Maita ME; Macica CM; Girardi EP
    Am J Physiol; 1991 Jan; 260(1 Pt 2):F110-8. PubMed ID: 1847009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blocking pannexin-1 alleviates cisplatin-induced acute kidney injury in mice by reducing renal inflammatory cell infiltration].
    Liu C; Huang L; Li C; Shen Y; Wang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):508-514. PubMed ID: 31140412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure.
    Forbes JM; Jandeleit-Dahm K; Allen TJ; Hewitson TD; Becker GJ; Jones CL
    Exp Nephrol; 2001; 9(5):309-16. PubMed ID: 11549848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.